Intermittent fasting increases growth differentiation factor 15 in females with overweight or obesity but not associated with food intake.
暂无分享,去创建一个
[1] H. Grill,et al. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms , 2022, Diabetes, obesity & metabolism.
[2] E. Richter,et al. GDF15 in Appetite and Exercise: Essential Player or Coincidental Bystander? , 2021, Endocrinology.
[3] B. Kemp,et al. AMPK mediates energetic stress‐induced liver GDF15 , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] S. O’Rahilly,et al. GDF15: A Hormone Conveying Somatic Distress to the Brain , 2020, Endocrine reviews.
[5] H. Grill,et al. GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss. , 2020, Cell reports.
[6] L. Heilbronn,et al. Intermittent fasting: What questions should we be asking? , 2020, Physiology & Behavior.
[7] H. Grill,et al. GDF15 Induces Anorexia through Nausea and Emesis. , 2020, Cell metabolism.
[8] S. O’Rahilly,et al. GDF15 mediates the effects of metformin on body weight and energy balance , 2019, Nature.
[9] G. Bray,et al. GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans , 2019, Cell Metabolism.
[10] L. Heilbronn,et al. Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight , 2019, Obesity.
[11] Yan Tang,et al. Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver , 2018, Redox biology.
[12] T. Cash-Mason,et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates , 2017, Nature Medicine.
[13] R. Shaw,et al. AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. , 2017, Molecular cell.
[14] J. Franklin,et al. Do ketogenic diets really suppress appetite? A systematic review and meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[15] K. Wollert,et al. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial. , 2012, European journal of endocrinology.